Yahoo answers: What is Mild hypertrophic changes around the knee joints (X-ray report included)?
-
My X-ray for knee joint AP/LAT, says: -hypertrophic changes noted around the knee joints. -Alignment and bone density are normal. -No evidence of lytic / sclerotic bone lesion. -No bony injury noted. -Soft tissues are normal. IMPRESSION: VERY...
07/06/12 -
Mild degenerative joint disease is a medical way of saying you have mild osteoarthritis in your knee. From injury or some other way the cartilage that cushions that knee has worn away or thinned...
Latest news about lytic bone disease
-
'Practice Changing' MRI Recommendations in Multiple Myeloma
However, he stressed, "MRI reveals the bone marrow infiltration and not the presence of lytic lesions, whereas WBLD CT or PET/CT (the CT part) can reveal osteolytic lesions. Thus, in asymptomatic patients with normal skeletal radiography or normal WBLD
Source: http://www.medscape.com/viewarticle/839000 -
UPDATE 2-FDA expands use of Imbruvica to treat rare form of blood cancer
(Adds analyst comment). By Natalie Grover. Jan 29 () - The U.S. Food and Drug Administration approved the expanded use of Imbruvica, sold by Johnson & Johnson and Pharmacyclics Inc, to treat Waldenström's macroglobulinemia (WM), a rare form
Source: http://www.reuters.com/article/2015/01/29/johnson-johnson-fda-imbruvica-idUSL4N0V86WE20150129 -
Amgen Submits Applications In The US And Europe For Kyprolis® (carfilzomib ...
"Multiple myeloma is an incurable blood cancer that often becomes resistant to treatment, underscoring the need for new therapeutic options that provide deep and durable responses to extend the time patients live without their disease progressing
Source: http://www.sys-con.com/node/3287987 -
ContraFect: An Emerging Anti-Infectious Biotechnology Company With 2 Unique ...
ContraFect (NASDAQ:CFRX) is a clinical-stage biotechnology company focused on the development of a pipeline (Figure 1) of lysin and antibody therapeutics for the treatment of drug-resistant infectious diseases. It's hypothesized that a single
Source: http://seekingalpha.com/article/2858496-contrafect-an-emerging-anti-infectious-biotechnology-company-with-2-unique-platforms-targeting-multi-drug-resistance -
Bone Disease in Multiple Myeloma
The recent identification of multiple molecular targets with key roles in the osteolytic process has illuminated our understanding of myeloma bone disease, and may transform our future approaches to providing multiple myeloma patients with optimal
Source: http://www.cancernetwork.com/oncology-journal/bone-disease-multiple-myeloma
Images lytic bone disease





http://www.livestrong.com/article/189271-what-are-the-causes-of-lytic-bone-lesions/
http://disease-overview.com/lytic-bone-disease.html
http://eradiology.bidmc.harvard.edu/LearningLab/musculo/Kallianos.pdf
http://en.wikipedia.org/wiki/Multiple_myeloma
http://disease-overview.com/lytic-bone-lesions.html